JAN 20, 2015 12:00 AM PST

Market Research Firm Cites Trends

WRITTEN BY: Ilene Schneider
What are the key healthcare trends of 2014? Which ones might be a factor next year and in subsequent years?

According to the market research firm Kalorama Information, which publishes forty to fifty detailed studies in healthcare markets every year, the list is based on the news events, growth rates of markets the firm studies and information requests the firm gets from industry participants. As reported in Pharmaceutical Processing, here are the top five of 2014:

Growth from BRIC nations was good but not as good as expected. BRIC, an acronym for the economies of Brazil, Russia, India and China combined, demonstrated economic growth that was faster than the United States markets but not as fast as in previous years. Goldman Sachs coined the acronym in a report from 2003, which speculated that by 2050 these four economies would be wealthier than most of the current major economic powers. The BRIC thesis posits that China and India will become the world's dominant suppliers of manufactured goods and services, respectively, while Brazil and Russia will become similarly dominant as suppliers of raw materials. Due to lower labor and production costs, many companies also cite BRIC as a source of foreign expansion opportunity.

Pharmaceutical Processing says, "For instance Brazil at 2.5, China at 7.7% -- high growth but not as high as 2010 (both countries at 10% growth). Kalorama believes this will impact manufacturer plans to use these emerging markets to counter slow revenue growth in developed markets."

The next trend cited in the list is that the next-generation sequencer has evolved into clinical medicine. The story says, "There is high interest in the healthcare industry in using lower cost, smaller size and fast DNA sequencing for better understanding of disease and specific abnormalities, particularly in enhancing the study of tumors. The increased use of sequencing may enhance some existing test products and may compete with others."

With the improvement of high-throughput biotechnologies and the rapid decrease in DNA sequencing cost and time, genomics-based personalized medicine has already been practiced in a number of prestigious places. Major companies are providing and improving the instrumentation.

A third trend is the interest in patient monitoring solutions and telemedicine for better outcomes and more efficient care. The article says that "remote patient monitoring systems inside hospitals or connecting healthcare workers to patients at home continue to demonstrate revenue growth and customer demand." Kalorama projects that the market will reach "29 billion by year end and will grow at a rate of 9% for the next four years."

The trend is especially significant in rural areas and underdeveloped countries where access to a flesh-and-blood doctor might not be readily available. Telemedicine also facilitates collaborations among colleagues all over the world, in the hope that elusive cures can be found. It has been discussed for many years, but technology is now making it a reality.

Fourth, Kalorama cites the demand for biopharmaceutical production, relating that "the need to produce new biopharmaceutical drugs is driving the market for the companies that will handle the production and for the equipment used in the process." The study says that the market demonstrated 11% revenue growth and reached 41 billion this year. According to Kalorama, "with the investment in recent years in biotechnology companies, this type of growth is expected to continue."

Finally, Kalorama says that medical device companies are growing by buying, relating that "several large device mergers were concluded or announced in 2014, most notably Medtronic and Covidien. In addition to several acquisitions by Stryker, Zimmer announced this year the acquisition of Biomet Inc. Becton Dickinson announced it would purchase CareFusion."

Bruce Carlson, publisher of Kalorama Information, says these trends cut across healthcare industries and will alter the way the market for healthcare products and services looks in 2015. As he explained, "While IVD makers wonder how sequencing figures into their strategies, device companies may look for the next acquisition target to counter what competitors have done. Healthcare systems will be eyeing telemedicine solutions, and investors will seek new biopharm drug companies with potential, and those companies will try to obtain production sources.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
OCT 05, 2020
Cell & Molecular Biology
Gaining Insight Into the Connection Between Depression and Stress
OCT 05, 2020
Gaining Insight Into the Connection Between Depression and Stress
Depression is a common mental illness, and stress is known to be an environmental influence that can increase the risk o ...
OCT 07, 2020
Genetics & Genomics
Researchers Confirm Cerebral Palsy Has a Genetic Component
OCT 07, 2020
Researchers Confirm Cerebral Palsy Has a Genetic Component
Scientists have confirmed previous studies that have suggested that some cases of cerebral palsy are due to a genetic mu ...
OCT 11, 2020
Cell & Molecular Biology
Newly-Found Molecules May Treat Neurodegeneration
OCT 11, 2020
Newly-Found Molecules May Treat Neurodegeneration
The NMDA receptor is known to play a crucial role in memory, and synaptic plasticity - where neurons change, altering ne ...
OCT 11, 2020
Plants & Animals
Fungal Disease Affecting Snakes Is More Widespread Than Thought
OCT 11, 2020
Fungal Disease Affecting Snakes Is More Widespread Than Thought
A team of researchers and personnel on military bases have reported in a project in which they looked for an emerging fu ...
OCT 22, 2020
Cell & Molecular Biology
How a Gene Variant Raises the Risk of Multiple Sclerosis
OCT 22, 2020
How a Gene Variant Raises the Risk of Multiple Sclerosis
Now that sequencing the whole human genome is easier, faster, and cheaper than it used to be, scientists have been able ...
OCT 22, 2020
Microbiology
SARS-CoV-2 Has Multiple Routes Into Cells
OCT 22, 2020
SARS-CoV-2 Has Multiple Routes Into Cells
Since the pandemic virus SARS-CoV-2 emerged on the scene late last year, it's left a trail of devastation around the glo ...
Loading Comments...